+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Pancreatic spasmolytic poly peptide 1. preparation and initial chemical characterization of a new poly peptide from porcine pancreas

Regulatory Peptides 3(3-4): 207-220
Pancreatic spasmolytic poly peptide 1. preparation and initial chemical characterization of a new poly peptide from porcine pancreas
A novel polypeptide, named pancreatic spasmolytic polypeptide (PSP), was discovered in a side-fraction from the purification of porcine insulin. PSP was prepared by 2 different purification methods based on combinations of precipitations, anion-exchange and cation-exchange chromatography. The highest yield obtained, 52 mg PSP/kg pancreas, indicates that the ocntent of PSP in porcine pancreas is about half the content of insulin. Both preparations appeared to be very pure as judged by basic disc electrophoresis, isoelectric focusing, analytical gel filtration and radioimmunoassays for various polypeptides known to be present in pancreas. The PSP molecule contains 106 amino acids (MW about 11,700). PSP is an acidic (isoelectric point, 4.4), non-glycosylated protein without free N-terminal amino groups, and with high contents of proline and cystine. The high content of S-S bridges (7/molecule), an unexpected low apparent MW determined by gel filtration, and a remarkable resistance towards treatment with trypsin and chymotrypsin, point to a compact structure of the PSP molecule.

(PDF 0-2 workdays service: $29.90)

Accession: 006059511

Related references

Preparation and characterization of pancreatic spasmolytic poly peptide a new poly peptide from porcine pancreas. Diabetologia 21(3): 288, 1981

Pancreatic spasmolytic poly peptide 2. radio immunological determination of pancreatic spasmolytic poly peptide in porcine tissues plasma and pancreatic juice. Regulatory Peptides 3(3-4): 221-230, 1982

Pancreatic spasmolytic poly peptide 3. pharmacology of a new porcine pancreatic poly peptide with spasmolytic and gastric acid secretion inhibitory effects. Regulatory Peptides 3(3-4): 231-244, 1982

Pancreatic spasmolytic polypeptide (PSP): I. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas. Regulatory Peptides 3(3-4): 207-219, 1982

Effects of poly peptide yy and pancreatic poly peptide on endocrine pancreas. Acta Physiologica Scandinavica 119(2): 123-126, 1983

Immuno cytochemical localization of the eicosa peptide fragment of the pancreatic poly peptide precursor a marker for true pancreatic poly peptide cells. Regulatory Peptides 8(3): 217-224, 1984

Vascular effects of peptide yy and peptide hi comparison with avian pancreatic poly peptide and vasoactive intestinal poly peptide. European Journal of Pharmacology 83(1-2): 143-146, 1982

Pancreatic poly peptide cells in the poly peptide rich lobe of the human pancreas are identified ultrastructurally and immuno cytochemically as f cells. Histochemistry 77(4): 511-524, 1983

Entero pancreatic axis for pancreatic poly peptide secretion with special reference to cholecystokinin pancreatic poly peptide relationship. Japanese Journal Of Medicine: 264, 1981

Intra venous ethanol alcohol induced pancreatic inhibition and plasma levels of pancreatic poly peptide vasoactive intestinal poly peptide and somatostatin in man. Gastroenterology 80(5 PART 2): 1293, 1981